Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) ✔ RFA-TR-23-016 R21 07/05/2023 06/02/2025 NA
Notice of Technical Assistance Webinar for June 21, 2022 submission date of Limited Competition: Clinical and Translational Science Awards (CTSA) Cons... ✔ NOT-TR-22-028 03/28/2022 Notice of Information
Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Al... ✘ NOT-HG-22-017 04/07/2022 Notice of Information
Notice to Extend the Due Date and Expiration Date of NOT-TR-23-019: Notice of Special Interest (NOSI): Availability of Administrative Supplements for ... ✔ NOT-TR-23-025 07/07/2023 Notice of Change to Funding Opportunity
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed ✔ PAR-23-268 UT1 04/18/2023 06/06/2025 NA
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) ✔ PAR-23-267 U43/U44 04/18/2023 06/06/2025 NA
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Drugg... ✔ NOT-TR-23-012 04/17/2023 Notice of Information
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) ✔ PAR-23-159 R21 04/13/2023 10/17/2024 NA
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial ... ✔ PAR-22-167 UG3/UH3 05/09/2022 10/17/2024 NA
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) ✘ PAR-22-184 U01 05/13/2022 08/18/2024 NA
Showing Row 101 to 110 of 414

Last updated on February 19, 2025